Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors
Abstract A type of novel rhodanine-based 4-anilinoquinazoline, which designed the combination between quinazoline as the backbone and various substituted biological rhodanine groups as the side chain, have been synthesized, and their antiproliferative act
5-Benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials
Herein we outline the antibacterial activity of amino acid containing thiazolidinediones and rhodanines against Gram-positive bacteria Staphylococcus aureus ATCC 31890, Staphylococcus epidermidis and Bacillus subtilis ATCC 6633. The rhodanine derivatives
Zvarec, Ondrej,Polyak, Steven W.,Tieu, William,Kuan, Kevin,Dai, Huanqin,Pedersen, Daniel Sejer,Morona, Renato,Zhang, Lixin,Booker, Grant W.,Abell, Andrew D.
experimental part
p. 2720 - 2722
(2012/05/31)
COMPOUNDS USEFUL AS HYPOGLYCEMIC AGENTS AND FOR TREATING ALZHEIMER'S DISEASE
Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulation
-
(2008/06/13)
More Articles about upstream products of 3785-78-2